"In our view this is a correction and not the start of a sustained bear market," Goldman Sachs said. DeepSeek sparked a $1 ...
Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.
Hedge fund stock-pickers lost billions of dollars on Monday in a rout in global technology shares sparked by the emergence of ...
Treasury yield is hovering just above a six-week low around 4.50% as investors continue to digest Wednesday’s monetary policy update from the Federal Reserve. The U.S. central bank left interest rates ...
Moderna (MRNA) stock falls as Goldman Sachs downgrades the COVID-19 vaccine maker to Neutral from Buy, citing a lack of ...
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
See the back-to-work policies of 10 investment banks, hedge funds, and asset managers, including BlackRock, Goldman Sachs, Citigroup, and more. The stock market is facing three challenges that ...
Goldman Sachs stock is not overvalued as growth in revenue and EPS is impressive. Click here to find out why I believe GS is ...
When news of Solomon’s bonus was released, a lot of folks here just rolled their eyes,” one equities trader told The Post.